Showing results 1 to 20 of 38
next >
| Preview | Issue Date | Title | Author(s) |
| 2000 | A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common b subunit | D'Andrea, R.; Gonda, T. |
| 2015 | A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone | Hahn, C.; Ross, D.; Feng, J.; Beligaswatte, A.; Hiwase, D.; Parker, W.; Ho, M.; Zawitkowski, M.; Ambler, K.; Cheetham, G.; Lee, Y.; Babic, M.; Butcher, C.; Engler, G.; Brown, A.; D'Andrea, R.; Lewis, I.; Schreiber, A.; To, L.; Scott, H. |
| 1997 | Activating mutations in cytokine receptors: implications for receptor function and role in disease. | Gonda, T.; D'Andrea, R. |
| 1995 | Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling | Jenkins, B.; D'Andrea, R.; Gonda, T. |
| 2000 | An oncogenic role of sphingosine kinase | Xia, P.; Gamble, J.; Wang, L.; Pitson, S.; Moretti, P.; Wattenberg, B.; D'Andrea, R.; Vadas, M. |
| 2010 | Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors | Hiwase, D.; White, D.; Powell, J.; Saunders, V.; Zrim, S.; Frede, A.; Guthridge, M.; Lopez, A.; D'Andrea, R.; To, L.; Vaz de Melo, J.; Kumar, S.; Hughes, T. |
| 2007 | Cellular origin and lineage specificity of the JAK2(V617F) allele in polycythemia vera | Butcher, C.; Hutton, J.; Hahn, U.; To, L.; Bardy, P.; Lewis, I.; D'Andrea, R. |
| 1999 | Cloning, characterization, and chromosomal location of a novel human K+-C1- cotransporter | Hiki, K.; D'Andrea, R.; Furze, J.; Crawford, J.; Woollatt, E.; Sutherland, G.; Vadas, M.; Gamble, J. |
| 2004 | Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation | Brown, A.; Peters, M.; D'Andrea, R.; Gonda, T. |
| 2012 | Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells | Wang, J.; Hughes, T.; Kok, C.; Saunders, V.; Frede, A.; Groot Obbink, K.; Osborn, M.; Somogyi, A.; D'Andrea, R.; White, D. |
| 2018 | Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes | Chong, C.-E.; Venugopal, P.; Stokes, P.; Lee, Y.; Brautigan, P.; Yeung, D.; Babic, M.; Engler, G.; Lane, S.; Klingler-Hoffmann, M.; Matthews, J.; D'Andrea, R.; Brown, A.; Hahn, C.; Scott, H. |
| 2014 | Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome | Tan, P.; Wei, A.; Mithraprabhu, S.; Cummings, N.; Liu, H.; Perugini, M.; Reed, K.; Avery, S.; Patil, S.; Walker, P.; Mollee, P.; Grigg, A.; D'Andrea, R.; Dear, A.; Spencer, A. |
| 2014 | Dynamic evolution of clonal epialleles revealed by methclone | Li, S.; Garrett-Bakelman, F.; Perl, A.; Luger, S.; Zhang, C.; To, B.; Lewis, I.; Brown, A.; D'Andrea, R.; Ross, M.; Levine, R.; Carroll, M.; Melnick, A.; Mason, C. |
| 1998 | Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common β chain in transgenic mice | D'Andrea, R.; Harrison-Findik, D.; Butcher, C.; Finnie, J.; Blumbergs, P.; Bartley, P.; McCormack, M.; Jones, K.; Rowland, R.; Gonda, T.; Vadas, M. |
| 2012 | Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors | Bard-Chapeau, E.; Jeyakani, J.; Kok, C.; Muller, J.; Chua, B.; Gunaratne, J.; Batagov, A.; Jenjaroenpun, P.; Kuznetsov, V.; Wei, C.; D'Andrea, R.; Bourque, G.; Jenkins, N.; Copeland, N. |
| 2000 | Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation | Pitson, S.; Moretti, P.; Zebol, J.; Xia, P.; Gamble, J.; Vadas, M.; D'Andrea, R.; Wattenberg, B. |
| 2009 | Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML | Powell, J.; Thomas, D.; Barry, E.; Kok, C.; McClure, B.; Tsykin, A.; To, L.; Brown, A.; Lewis, I.; Herbert, K.; Goodall, G.; Speed, T.; Asou, N.; Jacob, B.; Osato, M.; Haylock, D.; Nilsson, S.; D'Andrea, R.; Lopez, A.; Guthridge, M. |
| 2013 | GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations | Perugini, M.; Iarossi, D.; Kok, C.; Cummings, N.; Diakiw, S.; Brown, A.; Danner, S.; Bardy, P.; To, L.; Wei, A.; Lewis, I.; D'Andrea, R. |
| 2001 | GM-CSF binding to its receptor induces oligomerisation of the common beta-subunit | Mc Clure, B.; Woodcock, J.; Harrison-Findik, D.; Lopez, A.; D'Andrea, R. |
| 2013 | Hoxa9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of Hoxa9-dependent leukemia | Brumatti, G.; Salmanidis, M.; Kok, C.; Bilardi, R.; Sandow, J.; Silke, N.; Mason, K.; Visser, J.; Jabbour, A.; Glaser, S.; Okamoto, T.; Bouillet, P.; D'Andrea, R.; Ekert, P. |
